Low-dose aspirin affects the clinicopathological features of gastric cancer

Digestion

Volumn 73, Issue 1, 2006, Pages 54-59

  Hye, Jin Hwang ^a   Young, Hoon Youn ^a   Kim, Jie Hyun ^a   Jae, Bock Chung ^a   Yong, Chan Lee ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Aspirin; Chemoprevention; Gastric cancer

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL DISCOMFORT; ADULT; AGED; ANEMIA; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CARDIAC PATIENT; CASE CONTROL STUDY; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DYSPEPSIA; EPIGASTRIC PAIN; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEART PROTECTION; HEMATEMESIS; HISTOLOGY; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MALE; MELENA; NAUSEA; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STOMACH CANCER;

AGED; ASPIRIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; NEOPLASM STAGING; STOMACH NEOPLASMS;

EID: 33744455716     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092248     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156.
2. Forman D, Morris E, Eastwood A, Kleijnen J: Guidelines for the treatment of upper gastro-intestinal cancer. Lancet 2003;361:80.
3. Muscat JE, Stellman SD, Wynder EL: Nonsteroidal anti-inflammatory drugs and colorectal cancer. Cancer 1994;74:1847-1854.
4. Garcia-Rodriguez LA, Huerta-Alvarez C: Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 2001;12:88-93.
5. Thun MJ, Namboodiri MM, Heath CW Jr: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991:325:1593-1596.
6. Sturmer T, Glynn RJ, Lee IM, Manson JE, Buring JE, Hennekens CH: Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study. Ann Intern Med 1998:128:713-720.
7. Langman MJS, Cheng KK, Gilman EA, Lancashire RJ: Effect of anti-inflammatory drugs on overall risk of common cancer: case control study in general practice research database. BMJ 2000;320:1642-1646.
8. Zaridze D, Borisova E, Maximovitch D, Chkhikvadze V: Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia. Int J Cancer 1999:82:473-476.
9. Akre K, Ekstrom AM, Signorello LB, Hansson LE, Nyren O: Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. Br J Cancer 2001;84:965-968.
10. Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC: Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2003:95:1784-1791.
11. Rubio CA: Further studies on the therapeutic effect of indomethacin on esophageal tumors. Cancer 1986;58:1029-1031.
12. Funkhouser EM, Sharp GB: Aspirin and reduced risk of esophageal carcinoma. Cancer 1995;76:1116-1119.
13. Uefuji K, Ichikura T, Mochizuki H: Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas. J Surg Oncol 2001:76:2630.
14. Xue YW, Zhang QF, Zhu ZB, Wang Q, Fu SB: Expression of cyclooxygenase-2 and clinico-pathologic features in human gastric adenocarcinoma. World J Gastroenterol 2003;9:250-253.
15. Yamamoto H, Itoh F, Fukushima H, Hinoda Y, Imai K: Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability. Int J Cancer 1999;84:400-403.
16. Uefuji K, Ichikura T, Mochizuki H: Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin Cancer Res 2000;6:135-138.
17. Ohno R, Yoshinaga K, Fujita T, Hasegawa K, Iseki H, Tsunozaki H, Ichikawa W, Nihei Z, Sugihara K: Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 2001;91:1876-1881.
18. Joo YE, Oh WT, Rew JS, Park CS, Choi SK, Kim SJ: Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis. Digestion 2002:66:222-229.
19. Lauren P: The two histologic main types of gastric carcinoma. Acta Pathol Microbiol Scand 1965;63:31-49.
20. Watanabe H, Jass JR, Sobin LH: The Histological Typing of Oesophageal and Gastric Tumours. WHO International Histological Classification of Tumours. New York, Springer, 1990.
21. Misumi A, Murakami A, Harada K, Baba K, Akagi M: Definition of carcinoma of the gastric cardia. Langenbecks Arch Chir. 1989;374:221-226.
22. American Joint Committee on Cancer: Manual for Staging Cancer: Stomach Cancer. Philadelphia, Lippincott-Raven, 1997, pp 71-76.
23. Hudson N, Balsitis M, Filipowicz F, Hawkey CJ: Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993;34:748-751.
24. Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK, Chan FK: Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 2000;157:729-735.
25. Chen CN, Sung CT, Lin MT, Lee PH, Chang KJ: Clinicopathological association of cyclo-oxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma. Ann Surg 2001;233:183-188.
26. Lim HY, Joo HJ, Choi JH, Yi JW, Yang MS, Cho DY, Kim HS, Nam DK, Lee KB, Kim HC: Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer Res 2000;6:519-525.
27. Jalbert G, Castonguay A: Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett 1992;66:21-28.
28. Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y, Nagano K, Hori M: Cyclo-oxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 1998;274:1061-1067.
29. Fu SL, Wu YL, Zhang YP, Qiao MM, Chen Y: Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer. World J Gastroenterol 2004:10:1971-1974.
30. Hu PJ, Yu J, Zeng ZR, Leung WK, Lin HL, Tang BD, Bai AH, Sung JJ: Chemoprevention of gastric cancer by celecoxib in rats. Gut 2004;53:195-200.